Cross sectional study to investigate the 25-hydroxyvitamin D level and potentially influencing factors of pregnant women and their newborns in Germany

Cross sectional study to investigate the 25-hydroxyvitamin D level and potentially influencing factors of pregnant women and their newborns in Germany - Vitamin D in pregnancy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003245

Enrollment

328

Registered

2011-09-07

Start date

2011-03-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E55.9 E55

Interventions

Group 1: Vitamin D status of pregnant women and their newborns

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Pregnant women and their newborns, delivery at the St. Josefs Hospital Giessen

Exclusion criteria

Exclusion criteria: Hypercalcaemia, secondary hyperparathyroidism, granulomatosis, malabsorption diseases, history of chronic liver or kidney disease, intake of anticonvulsants or Glucocorticoids, outpatient delivery

Design outcomes

Primary

Measure	Time frame
Determining maternal and newborn serum 25-hydroxy-vitamin D at time of delivery using chemiluminescence immunoassay (CLIA)	—

Secondary

Measure	Time frame
Maternal serum and cord blood: parathyroid hormone, alkaline phosphatase and calcium at time of delivery	—

Countries

Germany

Contacts

Public ContactCatrin Würtz

Institut für Ernährungswissenschaft

catrin-w@web.de0641/9939-056

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026